Edelweiss Small Cap Fund Regular-Growth
The fund is rated 1.5 stars. Investment selection within each asset type and balance between returns and downside risk provided some support. Investment selection within each industry did not provide enough support for a higher rating. Higher annual fee of 1.98% was a minor drawback.
This fund has a ok track record with Asset Selection/Timing, a bad track record with Stock Selection/Timing, a ok risk-reward ratio. It is important to note, however, that this fund has a 7252.911 AUM and a 1.98 expense ratio. Considering all these factors, we have rated this fund as 1.5 star.
Our score weighs long-term performance, risk and consistency — not just past returns.
Returns
As of 7 Oct 2026
Risk ratios
As of 30 Sep 2026
Portfolio
As of 31 Aug 2026
Market-cap split
Sector allocation
Holdings (96)
| Holding | % of fund | Value | Shares |
|---|---|---|---|
| City Union Bank Ltd. | 3.17% | ₹229.57 Cr | 1,00,16,786 |
| Multi Commodity Exchange Of India Ltd. | 2.64% | ₹191.15 Cr | 5,62,215 |
| Karur Vysya Bank Ltd. | 2.64% | ₹191.49 Cr | 55,08,963 |
| PNB Housing Finance Ltd. | 2.34% | ₹169.49 Cr | 14,75,493 |
| Avalon Technologies Ltd. | 2.27% | ₹164.67 Cr | 6,93,834 |
| Gabriel India Ltd. | 2.18% | ₹158.06 Cr | 10,99,234 |
| Kei Industries Ltd. | 2.06% | ₹149.67 Cr | 2,60,735 |
| Ajanta Pharma Ltd. | 1.94% | ₹140.64 Cr | 3,90,447 |
| Fortis Healthcare Ltd. | 1.92% | ₹139.09 Cr | 15,33,721 |
| Radico Khaitan Ltd. | 1.84% | ₹133.17 Cr | 2,96,927 |
Fund details
Long-term capital appreciation. Investments predominantly in equity and equity related securities of small cap companies.
The scheme seeks to generate long term capital appreciation from a portfolio that predominantly invests in equity and equity related securities of small cap companies.
Exit load of 1%, if redeemed within 90 days.